tiprankstipranks
Trending News
More News >
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
US Market

PDS Biotechnology (PDSB) Income Statement

Compare
791 Followers

PDS Biotechnology Income Statement

Last quarter (Q3 2025), PDS Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, PDS Biotechnology's net income was $-9.01M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -59.79K$ -57.33K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 36.26M$ 43.05M$ 41.67M$ 21.44M$ 14.90M
Depreciation and Amortization
$ 59.79K$ 57.33K$ 86.00$ 5.36K$ 15.61K
EBITDA
$ -33.75M$ -40.09M$ -40.74M$ -21.43M$ -14.89M
Operating Income
$ -36.32M$ -43.05M$ -41.67M$ -21.44M$ -14.90M
Other Income/Expenses
$ -2.16M$ -1.30M$ -381.34K$ 4.35K$ 55.01K
Pretax Income
$ -38.48M$ -44.35M$ -42.05M$ -21.43M$ -14.85M
Net Income
$ -37.61M$ -42.94M$ -40.85M$ -16.92M$ -14.85M
Per Share Metrics
Basic EPS
$ -1.03$ -1.39$ -1.43$ -0.66$ -0.89
Diluted EPS
$ -1.03$ -1.39$ -1.43$ -0.66$ -0.89
Weighted Average Shares Outstanding
36.45M 30.95M 28.60M 25.60M 16.75M
Weighted Average Shares Outstanding (Diluted)
36.45M 30.95M 28.60M 25.60M 16.75M
Currency in USD

PDS Biotechnology Earnings and Revenue History